In the Face of a Pandemic, Can Pharma Shift Gears?

N. Craig Smith, Markus Schölz

Research output: Contribution to journalArticle


The pharmaceutical industry’s competition-based model could be a real liability in the race to develop drugs and vaccines to combat COVID-19. A better approach would be for pharma companies and partners outside the industry to temporarily hit the pause button on their traditional ways of doing business and find new ways to work together, as some scientists are now advocating.
Original languageEnglish
JournalMIT Sloan Management Review
Publication statusPublished - 16 Apr 2020


  • Pharmaceuticals
  • Pandemic
  • Breakthrough Innovation
  • Vaccines
  • Collaboration


Dive into the research topics of 'In the Face of a Pandemic, Can Pharma Shift Gears?'. Together they form a unique fingerprint.

Cite this